Fri, Aug 1, 2014, 6:34 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Abbott Laboratories Message Board

  • catdog12347 catdog12347 Jan 16, 2012 6:16 PM Flag

    CHECK OUT ADXS

    They just started their GOG trial in the US that will supplement the Indian trial which is 80% complete(phase 2). They already have 1 total response and 3 other partial responses in the first 31 patients dosed with more to come. They will be giving Efficacy results on January 25th at the world vaccine congress. They are also running a parallel phase 2 in CIN which looks to be 1/2 way done and will be reporting on their low dose cohort toward the end of february.
    They also have a head and neck cancer trial starting soon in the UK (phase 2) that the CRUK will fund 100% through phase 3.
    Their cost of production is 6.00 a dose and have had 0 serious side effects in over 300 administrations.
    Oh and I forgot to mention, We've got like 3 previous(?) Bristol Meyers Squibb employees working at our little unknown company!
    WERE CURRENTLY TRADING AT .165 CENTS A SHARE!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ABT
42.03-0.09(-0.21%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.